New research in Blood Cancer Discovery shows that intravenous immunoglobulin (IVIg) reduced the risk of severe infections by 90% in patients with multiple myeloma undergoing treatment with an anti-BCMA bispecific antibody.
Sep 28, 2023
0
14
A study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has revealed crucial insights into the role of the histone methyltransferase NSD2 and its ...
Sep 12, 2023
0
2
Younger adults with newly diagnosed multiple myeloma who receive an autologous stem cell transplant (auto-HCT) have a median progression-free survival (PFS) of approximately 3.5 years and a median overall survival (OS) of ...
Jul 27, 2023
0
23
Multiple myeloma (MM) symptoms are generally nonspecific, according to a study published online June 25 in Cancers.
Jul 19, 2023
0
0
Combining five existing drugs can keep a highly aggressive type of bone marrow cancer at bay for longer, an innovative trial has shown.
Jun 23, 2023
0
20
Researchers at the Cima University of Navarra (Spain), in collaboration with the Spanish Myeloma Group (GEM-PETHEMA), have developed a calculator that identifies patients with multiple myeloma and primary systemic amyloidosis ...
May 4, 2023
0
8
Numerous studies have shown that people from racial and ethnic minority groups are underrepresented in clinical trials of new medical treatments for multiple myeloma. A study published today in the Blood Journal suggests ...
May 4, 2023
0
13
For patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in BMC Cancer.
Apr 25, 2023
0
17
Indiana University Melvin and Bren Simon Comprehensive Cancer Center served as the lead site for a promising first-in-human clinical trial for patients with relapsed multiple myeloma. Patients treated with higher doses of ...
Apr 17, 2023
0
2
Scientists have found a new way to predict which patients with the blood cancer myeloma will benefit the most from a treatment often used to help keep the disease from coming back after a stem cell transplant.
Mar 20, 2023
0
15
